🔥🐔 BizChicken 🐔🔥

Companies Similar to OpGen, Inc.

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Precigen, Inc.

Precigen, Inc. logo
Market Cap: Low
Employees: Low

gene and cellular therapies

Precigen, Inc. is focused on discovering and developing advanced gene and cellular therapies, disease-modifying therapeutics, and genetic engineering technologies for regenerative medicine and other applications.

Tags: biotechnology, cellular therapy, gene therapy, genetic engineering, regenerative medicine

Symbol: PGEN

Recent Price: $0.93

Industry: Biotechnology

CEO: Dr. Helen Sabzevari MPH, Ph.D.

Sector: Healthcare

Employees: 202

Address: 20374 Seneca Meadows Parkway, Germantown, MD 20876

Phone: 301 556 9900

Last updated: 2024-12-31

MacroGenics, Inc.

MacroGenics, Inc. logo
Market Cap: Low
Employees: Medium

MARGENZA (margetuximab-cmkb)

Macro Genics, Inc. is a biopharmaceutical company that develops and commercializes antibody-based therapeutics to treat cancer, including the approved product MARGENZA for metastatic HER2-positive breast cancer and a pipeline of immuno-oncology candidates.

Tags: HER2-positive, antibody-based therapeutics, biopharmaceutical, cancer treatment, immuno-oncology

Symbol: MGNX

Recent Price: $3.23

Industry: Biotechnology

CEO: Dr. Scott Koenig M.D., Ph.D.

Sector: Healthcare

Employees: 339

Address: 9704 Medical Center Drive, Rockville, MD 20850

Phone: 301 251 5172

Last updated: 2024-12-31

OmniAb, Inc.

OmniAb, Inc. logo
Market Cap: Medium
Employees: Low

Omni Ab platform

Omni Ab, Inc., a biotechnology company, provides therapeutic antibody discovery technologies in the United States. The company's platform leverages transgenic animals to generate human-like antibodies for therapeutic applications.

Tags: biotechnology, discovery platform, therapeutic antibodies, transgenic animals

Symbol: OABI

Recent Price: $3.56

Industry: Biotechnology

CEO: Mr. Matthew W. Foehr

Sector: Healthcare

Employees: 106

Address: 5980 Horton Street, EmeryVille, CA 94608

Phone: 510 250 7800

Leadership

  • Matt Foehr, Chief Executive Officer
  • Kurt Gustafson, Chief Financial Officer
  • Charles Berkman, JD, Chief Legal Officer and Secretary
  • Yasmina Abdiche, PhD, Vice President, Exploratory Research
  • Laurel Bernstein, PhD, Vice President, Intellectual Property
  • Neil Castle, PhD, Vice President, Biology
  • Bob Chen, PhD, Sr. Director, Discovery Systems
  • Ellen Collarini, PhD, Sr. Director, Cell Biology
  • Bill Harriman, PhD, Sr. Vice President, Antibody Discovery
  • Christel Iffland, PhD, Sr. Vice President, Antibody Technologies
  • Shelley Izquierdo, PhD, Sr. Director, Antibody Discovery
  • Doug Krafte, PhD, Site Head – Durham, North Carolina Sr. Vice President, Ion Channels/Transporters
  • Phil Leighton, PhD, Fellow
  • Cia McCaffrey, Vice President, People and Talent
  • Anil Nair, PhD, Vice President, In Silico Discovery
  • Todd Pettingill, CFA, Vice President, Business Development and Strategy
  • Chris Silvia, PhD, Vice President, Data Sciences and Corporate IT
  • Eric Vajda, PhD, Vice President, Preclinical R&D
  • Marie-Cecile van de Lavoir, DVM, PhD, Sr. Vice President, Technical Operations and Genetics
  • Donna Ventura, CPA, Sr. Vice President, Corporate Controller
  • Carolyn R. Bertozzi, PhD, Board Member
  • Sarah Boyce, President and Chief Executive Officer
  • Jennifer Cochran, PhD, Board Member
  • Matthew W. Foehr, President and Chief Executive Officer
  • John Higgins, Board Chair
  • Steve Love, Chief Financial Officer

Last updated: 2024-12-31

Acrivon Therapeutics, Inc. Common Stock

Acrivon Therapeutics, Inc. Common Stock logo
Market Cap: Low
Employees: Lowest

Acrivon Predictive Precision Proteomics

Acrivon Therapeutics is a clinical stage biopharmaceutical company developing oncology medicines using a proteomics-based platform to identify patient responders. Their lead candidate, ACR-368, is in Phase 2 trials for various cancers.

Tags: ACR-368, CHK1, CHK2, biopharmaceutical, clinical trials, oncology, precision medicine, proteomics

Symbol: ACRV

Recent Price: $5.41

Industry: Biotechnology

CEO: Dr. Peter Blume-Jensen M.D., Ph.D.

Sector: Healthcare

Employees: 58

Address: 480 Arsenal Way, Watertown, MA 02472

Phone: 617-207-8979

Last updated: 2024-12-31

Agenus Inc.

Agenus Inc. logo
Market Cap: Low
Employees: Medium

Retrocyte Display

Agenus Inc. is a clinical-stage immuno-oncology company that discovers and develops immuno-oncology products, offering antibody expression platforms, vaccine programs, and various monoclonal antibodies for cancer treatment.

Tags: antibody expression, cancer treatment, clinical trials, immuno-oncology, vaccine development

Symbol: AGEN

Recent Price: $2.69

Industry: Biotechnology

CEO: Dr. Garo H. Armen Ph.D.

Sector: Healthcare

Employees: 389

Address: 3 Forbes Road, Lexington, MA 02421-7305

Phone: 781 674 4400

Last updated: 2024-12-31

Akoya Biosciences, Inc.

Akoya Biosciences, Inc. logo
Market Cap: Low
Employees: Medium

Pheno Cycler, Pheno Imager, Proxima, in Form Tissue, Phenoptr

Akoya Biosciences, Inc. is a life sciences technology company that provides spatial biology solutions aimed at transforming discovery and clinical research worldwide through products like Pheno Cycler and Pheno Imager.

Tags: Pheno Cycler, Pheno Imager, biopharma services, clinical research, life sciences, spatial biology

Symbol: AKYA

Recent Price: $2.38

Industry: Medical - Instruments & Supplies

CEO: Mr. Brian McKelligon

Sector: Healthcare

Employees: 330

Address: 100 Campus Drive, Marlborough, MA 01752

Phone: 855 896 8401

Last updated: 2024-12-31

Aura Biosciences, Inc.

Aura Biosciences, Inc. logo
Market Cap: Medium
Employees: Low

AU-011

Aura Biosciences, Inc. operates as a biotechnology company developing virus-like drug conjugates (VDC) platform for treating ocular and urologic oncology tumors, with a focus on AU-011 for choroidal melanoma.

Tags: VDC technology, biotechnology, cancer therapy, choroidal melanoma, ocular oncology, oncology

Symbol: AURA

Recent Price: $8.13

Industry: Biotechnology

CEO: Dr. Elisabet de los Pinos Ph.D.

Sector: Healthcare

Employees: 88

Address: 85 Bolton Street, Cambridge, MA 02140

Phone: 617 500 8864

Leadership

  • David Johnson, Chairman
  • Elisabet de los Pinos, PhD, Chief Executive Officer
  • Giovanni Mariggi, PhD, Director
  • Antony Mattessich, Director
  • Sapna Srivastava, PhD, Director
  • Karan Takhar, Director

Last updated: 2024-12-31

AxoGen, Inc.

AxoGen, Inc. logo
Market Cap: Medium
Employees: Medium

Peripheral nerve surgical solutions

Axo Gen, Inc. develops and markets surgical solutions for addressing physical damage or transection of peripheral nerves, offering products like nerve grafts and protective wraps.

Tags: biotech, nerve protection, nerve repair, peripheral nerves, surgical solutions

Symbol: AXGN

Recent Price: $16.49

Industry: Medical - Devices

CEO: Mr. Nir Naor C.F.A., CPA, L.L.M., M.B.A.

Sector: Healthcare

Employees: 426

Address: 13631 Progress Boulevard, Alachua, FL 32615

Phone: 386 462 6800

Last updated: 2024-12-31

Precision BioSciences, Inc.

Precision BioSciences, Inc. logo
Market Cap: Lowest
Employees: Low

ARCUS

Precision Bio Sciences, Inc. is a clinical stage gene editing company specializing in in vivo gene editing and ex vivo allogeneic CAR T therapies, including the ARCUS genome editing platform and various investigational CAR T immunotherapies.

Tags: CAR T therapies, allogeneic CAR T, clinical stage, gene editing, genetic disorders, immunotherapy

Symbol: DTIL

Recent Price: $4.26

Industry: Biotechnology

CEO: Mr. Michael Amoroso

Sector: Healthcare

Employees: 109

Address: 302 East Pettigrew Street, Durham, NC 27701

Phone: 919 314 5512

Last updated: 2024-12-31

Generation Bio Co.

Generation Bio Co. logo
Market Cap: Low
Employees: Low

genetic medicines

Generation Bio Co. is a genetic medicines company developing therapies for rare and prevalent diseases, with a focus on the liver, retina, skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and is headquartered in Cambridge, Massachusetts.

Tags: CNS, genetic medicines, liver, oncology, prevalent diseases, rare diseases, retina, skeletal muscle

Symbol: GBIO

Recent Price: $1.06

Industry: Biotechnology

CEO: Dr. Cameron Geoffrey McDonough M.D.

Sector: Healthcare

Employees: 174

Address: 301 Binney Street, Cambridge, MA 02142

Phone: 617 655 7500

Last updated: 2024-12-31

Imunon, Inc.

Imunon, Inc. logo
Market Cap: Lowest
Employees: Lowest

GEN-1, Thermo Dox

Imunon, Inc. is a clinical stage biotechnology company specializing in the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies, focusing on products such as GEN-1 for ovarian cancer and Thermo Dox for various cancer indications.

Tags: Biotechnology, Cancer Treatment, DNA Therapies, Immunotherapy, Vaccines

Symbol: IMNN

Recent Price: $0.82

Industry: Biotechnology

CEO: Dr. Stacy R. Lindborg Ph.D.

Sector: Healthcare

Employees: 33

Address: 997 Lenox Drive, Lawrenceville, NJ 08648

Phone: 609 896 9100

Leadership

  • Stacy R. Lindborg, PhD, President, Chief Executive Officer, and Board Director
  • David Gaiero, Chief Financial Officer
  • Khursheed Anwer, PhD, MBA, Executive Vice President and Chief Science Officer
  • Kristin Longobardi, MBA, Senior Vice President, Strategic Operations
  • Susan Eylward, General Counsel and Corporate Secretary
  • Michael H. Tardugno,
  • Frederick J. Fritz,
  • Donald Braun, PhD,
  • Christine Pellizzari, JD,
  • James E. Dentzer,

Last updated: 2024-12-31

Myriad Genetics, Inc.

Myriad Genetics, Inc. logo
Market Cap: High
Employees: High

My Risk Hereditary Cancer Test

Myriad Genetics, Inc. is a genetic testing and precision medicine company that develops and commercializes genetic tests for oncology, women's health, and mental health applications.

Tags: DNA sequencing, genetic testing, mental health, oncology, precision medicine, women's health

Symbol: MYGN

Recent Price: $13.63

Industry: Medical - Diagnostics & Research

CEO: Mr. Paul J. Diaz

Sector: Healthcare

Employees: 2700

Address: 320 Wakara Way, Salt Lake City, UT 84108

Phone: 801 584 3600

Last updated: 2024-12-31

NeoGenomics, Inc.

NeoGenomics, Inc. logo
Market Cap: High
Employees: High

Cancer-focused testing services

Neo Genomics, Inc. operates a network of cancer-focused testing laboratories offering various services such as cytogenetics, fluorescence in-situ hybridization, flow cytometry, immunohistochemistry, digital imaging, and molecular testing.

Tags: cancer testing, cytogenetics, flow cytometry, laboratories, molecular testing, oncology

Symbol: NEO

Recent Price: $16.92

Industry: Medical - Diagnostics & Research

CEO: Mr. Christopher Michael Smith BSc

Sector: Healthcare

Employees: 2100

Address: 9490 NeoGenomics Way, Fort Myers, FL 33912

Phone: 239 768 0600

Leadership

  • Chris Smith, Chief Executive Officer
  • Jeff Sherman, Chief Financial Officer
  • Warren Stone, Chief Commercial Officer
  • Melody Harris, Chief Operations Officer & President, Informatics
  • Ali Olivo, Executive Vice President, General Counsel & Business Development
  • Hutan Hashemi, JD, Chief Compliance Officer
  • Nathan Montgomery, MD, PhD, Vice President, Medical Services
  • Gary Passman, Chief Culture Officer
  • Kareem Saad, Head of Strategy and Transformation
  • Lynn A. Tetrault, Chair of the Board
  • Bruce K. Crowther, Board Member
  • Elizabeth Floegel, Board Member
  • Neil Gunn, Board Member
  • Alison L. Hannah, MD, Board Member
  • Stephen Kanovsky, Board Member
  • Michael A. Kelly, Board Member
  • David Perez, Board Member
  • Tony Zook, Board Member
  • Derek Lyle, MD, Chief Medical Officer
  • Vladislav Chizhevsky, MD SSBBP, Medical Director, Aliso Viejo, California
  • J. Christopher Mixon, MD, Medical Director, Nashville, Tennessee
  • Anahit Nowrouzi, MD, Medical Director, Fort Myers, Florida
  • Tricia Peters, MD, Medical Director, Houston, Texas Molecular Pathologist, Pharma Services
  • Yin Xu, MD PhD FCAP, Medical Director, Carlsbad and Atlanta; Global Medical Director, Pharma Services
  • Renuka Agrawal, MD, Senior Hematopathologist
  • Todd S. Barry, MD PhD, Senior Hematopathologist
  • Bora Baysal, MD, PhD, Senior Hematopathologist
  • Saskia Boisot, MD, Senior Hematopathologist
  • Wayne W. Chen, MD PhD, Director of Hematopathology Services
  • Rachel Flamholz, MD, Senior Hematopathologist
  • Michael Hayes, MD, Senior Hematopathologist / Surgical Pathologist
  • Anselm Hii, MD, Director of Hematopathology Services
  • Thanh Ho, MD, Senior Hematopathologist
  • Kim Janatpour, MD MA, Senior Hematopathologist
  • Shiping Jiang, MD PhD, Senior Hematopathologist and Surgical Pathologist
  • Sameer S. Khatri, MD, Hematopathologist
  • Madeleine Kraus, MD, Senior Hematopathologist
  • Brian Kwok, MD FCAP, Corporate Director of Hematopathology
  • Keming Lin, MD MS FCAP, Senior Hematopathologist
  • Robert Lin, MD, Senior Hematopathologist
  • Russell L. Maiese, M.D., Senior Hematopathologist
  • Mojdeh Naghashpour, MD PhD, Senior Hematopathologist
  • Viera Nelson, MD, Senior Hematopathologist
  • Dennis P. O’Malley, MD, Senior Hematopathologist
  • Anthony Padula, MD, Senior Hematopathologist
  • Munir Shahjahan, MD MPH, Senior Hematopathologist
  • Jesalyn J. Taylor, MD, Senior Hematopathologist
  • Jian-Feng Wang, MD PhD, Senior Hematopathologist
  • Zhao Wu, MD PhD FCAP, Senior Hematopathologist
  • Aine Yung, MD FCAP, Senior Hematopathologist
  • Sadiq Zaman, MD, Senior Hematopathologist
  • Guohua Zhao, MD PhD, Senior Hematopathologist
  • Mitual Amin, MD, Senior Surgical Pathologist
  • Jerry Chu, MD PhD, Senior Surgical Pathologist
  • Ted Farzaneh, MD, Senior Surgical Pathologist
  • Thomas K. Lee, MD PhD, Director of Surgical Pathology Services
  • Takako Mitsuhashi, MD PhD, Senior Dermatopathologist and Surgical Pathologist
  • Robert Schwartz, MD, Senior Surgical Pathologist
  • Yae K (Kay) Suh, MD, Senior Surgical Pathologist
  • Matthew Geller, DO, Molecular Pathologist
  • Hao Ho, MD, Molecular Pathologist
  • Jennifer Hummel, MD, Senior Molecular Pathologist
  • Armen Kaysan, MD, Molecular Pathologist
  • Kalpana S. Reddy, MD, Hematopathologist and Molecular Pathologist
  • Saed Sadeghi, MD, Molecular Pathologist
  • Ying Wang, MD PhD, Molecular Pathologist
  • Shehla Arain, MD, Senior Surgical Pathologist, Pharma Services
  • Chunghun George Chang, md, Surgical and Hemepath Pathologist, Pharma Services
  • Indu Gupta, MD, Surgical Pathologist, Pharma Services
  • Valerie Harris-Morris, MD, Hemepath Pathologist, Pharma Services
  • Albert Ho, Director of Pharma Pathology Services
  • Henry Tsai, MD PhD, Surgical Pathologist, Pharma Services
  • Sujata Chakraborty, PhD FACMGG, Director, Cytogenetics and Molecular Genetics
  • Li Cheng, PhD FACMG, Associate Director of Cytogenetics
  • Liang Dong, MD PhD, Director of Cytogenetic Services
  • Mohamed M. Elnaggar, MD MS FACMG, Director of Cytogenetic Services
  • Michele Hibbard/Kempik, PhD FACMG, Director of Genetics
  • Fernando J. López-Díaz, PhD, Director of Clinical Science, Research and Development
  • John R. McGill, PhD FACMGG, Medical Director of Cytogenetics and Technical Director of FISH
  • Mike Nahorski, PhD, Director, Clinical and Scientific Alliances
  • Farzad Nooraie, MD, Director of Cytogenetic Services
  • Róisín Puentes, PharmD, PhD, Medical Science Liaison, Medical Affairs
  • Siby Sebastian, Ph.D, FACMGG, DABCC, Lab Director, Research Triangle Park (RTP), North Carolina
  • Guoxian Sun, MD DABMG FACMG, Director of Cytogenetic Services
  • Jadwiga Szymanska, PhD FACMG, Director of Cytogenetics
  • Maya Thangavelu, PhD, Medical Director of Cytogenetics and Technical Director of FISH
  • Qinqin Zha, PhD, Principal Scientist, Associate Director, Scientific Affairs
  • John N. Allan, MD, Scientific Advisory Board Member
  • Rafael Bejar, MD, PhD, Scientific Advisory Board Member
  • James R. Berenson, MD, Scientific Advisory Board Member
  • Riccardo Dalla-Favera, PhD, Scientific Advisory Board Member
  • James Downing, MD, Scientific Advisory Board Member
  • Bernard A Fox, PhD, Scientific Advisory Board Member
  • Gregory Hess, MD, Scientific Advisory Board Member
  • Hatim Husain, MD, Scientific Advisory Board Member
  • Tibor Kovacsovics, MD, Scientific Advisory Board Member
  • Razelle Kurzrock, MD, Scientific Advisory Board Member
  • Gail J. Roboz, MD, Scientific Advisory Board Member
  • Steven T. Rosen, MD, FACP, FASCO, FAIMBE, Scientific Advisory Board Member
  • Mark A. Rubin, MD, Scientific Advisory Board Member

Last updated: 2024-12-31

Omega Therapeutics, Inc.

Omega Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Low

OMEGA Epigenomic Programming platform

Omega Therapeutics, Inc. is a development-stage biopharmaceutical company leveraging its OMEGA Epigenomic Programming platform to utilize the power of epigenetics for therapeutic interventions across various diseases.

Tags: biopharmaceutical, chronic liver diseases, corneal regeneration, epigenetics, gene control, idiopathic pulmonary fibrosis

Symbol: OMGA

Recent Price: $0.80

Industry: Biotechnology

CEO: Mr. Mahesh Karande

Sector: Healthcare

Employees: 93

Address: 20 Acorn Park Drive, Cambridge, MA 02140

Phone: 617 949 4360

Leadership

  • Mahesh Karande, President & Chief Executive Officer
  • Kaan Certel, Ph.D., Chief Business Officer
  • Jennifer Nelson, Ph.D., Senior Vice President, Research
  • Tony Mullin, Chief People Officer
  • Barbara Chan, Senior Vice President, Finance and Chief Accounting Officer
  • Lisamarie Fahy, Senior Vice President, Clinical Development Operations
  • Joe Newman, Ph.D., Senior Vice President, Early Discovery
  • Jeff Atkinson, Ph.D., Vice President, Technical Operations
  • Eva Stroynowski, Senior Vice President, Investor Relations and Corporate Affairs

Last updated: 2024-12-31

OpGen, Inc.

OpGen, Inc. logo
Market Cap: Lowest
Employees: Low

Acuitas AMR Gene Panel, ARES Technology Platform, Unyvero Platform

Op Gen, Inc. is a precision medicine company focused on developing and commercializing molecular microbiology solutions, including IVD tests for antimicrobial resistance and automated molecular diagnostics platforms.

Tags: Antimicrobial Resistance, Artificial Intelligence, Diagnostics, Molecular Microbiology, Next Generation Sequencing, Precision Medicine

Symbol: OPGN

Recent Price: $0.62

Industry: Medical - Diagnostics & Research

CEO: Mr. Honjian Tan

Sector: Healthcare

Employees: 85

Address: 9717 Key West Avenue, Rockville, MD 20850

Phone: 240 813 1260

Leadership

  • John Tan Honjian, Chief Executive Officer and Chairman
  • David E. Lazar, President
  • David Caplon, Corporate Controller
  • Christian-Laurent Bonte, Independent Director
  • Victor Chua Kok Hoe, Independent Director
  • Ken Lim Zhao Qi, Independent Director
  • Ethan Low Yu Jie, Director
  • Constance Wong Poh Yin, Director

Last updated: 2024-12-31

PepGen Inc.

PepGen Inc. logo
Market Cap: Low
Employees: Low

PGN-EDO51

Pep Gen Inc. is a clinical-stage biotechnology company developing oligonucleotide therapeutics for neuromuscular and neurologic diseases. Its lead product, PGN-EDO51, is in Phase I trials for Duchenne muscular dystrophy.

Tags: Duchenne muscular dystrophy, biotechnology, clinical trials, neuromuscular diseases, oligonucleotide therapeutics

Symbol: PEPG

Recent Price: $3.83

Industry: Biotechnology

CEO: Dr. James G. McArthur Ph.D.

Sector: Healthcare

Employees: 72

Address: 245 Main Street, Cambridge, MA 02142

Phone: 781-797-0979

Last updated: 2024-12-31

10x Genomics, Inc.

10x Genomics, Inc. logo
Market Cap: High
Employees: Medium

chromium instruments

10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems globally. Their products include chromium instruments and single cell solutions for gene expression and immune profiling.

Tags: biological systems, chromium instruments, epigenetics, gene expression, immune profiling, life science, technology

Symbol: TXG

Recent Price: $14.35

Industry: Medical - Healthcare Information Services

CEO: Dr. Serge Saxonov Ph.D.

Sector: Healthcare

Employees: 1259

Address: 6230 Stoneridge Mall Road, Pleasanton, CA 94588-3260

Phone: 925 401 7300

Last updated: 2024-12-31

Veracyte, Inc.

Veracyte, Inc. logo
Market Cap: High
Employees: Medium

Afirma Genomic Sequencing Classifier, Xpression Atlas, Decipher Prostate, Prosigna Breast Cancer Assay, Percepta Genomic Sequencing Classifier, Envisia Genomic Classifier, Immunoscore Colon Cancer test

Veracyte, Inc. operates as a diagnostics company worldwide, providing genomic testing solutions for various cancers and diseases, aiming to improve outcomes by avoiding unnecessary surgeries and enhancing treatment decisions.

Tags: Biotechnology, Cancer Diagnosis, Diagnostics, Genomic Testing, Healthcare, Medical Devices

Symbol: VCYT

Recent Price: $40.00

Industry: Biotechnology

CEO: Mr. Marc A. Stapley

Sector: Healthcare

Employees: 815

Address: 6000 Shoreline Court, South San Francisco, CA 94080

Phone: 650 243 6300

Last updated: 2024-12-31

Avanos Medical, Inc.

Avanos Medical, Inc. logo
Market Cap: Medium
Employees: High

Mic-Key, Corpak, Neo Med, Ballard, Microcuff, Endoclear, On-Q, amb IT, Game Ready, Coolief

Avanos Medical, Inc. is a medical technology company focused on delivering medical device solutions globally. They offer chronic care products in digestive and respiratory health, and non-opioid pain solutions.

Tags: chronic care, digestive health, medical technology, non-opioid pain solutions, respiratory health

Symbol: AVNS

Recent Price: $15.58

Industry: Medical - Devices

CEO: Mr. Michael C. Greiner

Sector: Healthcare

Employees: 3771

Address: 5405 Windward Parkway, Alpharetta, GA 30004

Phone: 844 428 2667

Last updated: 2024-12-31

Orgenesis Inc.

Orgenesis Inc. logo
Market Cap: Lowest
Employees: Low

Point of Care (POCare) platform

Orgenesis Inc. is a biotech company focusing on cell and gene therapies. It offers a Point of Care (POCare) platform with a pipeline of POCare therapeutics produced in automated systems, targeting autologous therapies near the patient's point of care.

Tags: POCare, autologous therapies, biotech, cell therapy, gene therapy

Symbol: ORGS

Recent Price: $2.11

Industry: Biotechnology

CEO: Ms. Vered Caplan M.Sc.

Sector: Healthcare

Employees: 146

Address: 20271 Goldenrod Lane, Germantown, MD 20876

Phone: 480 659 6404

Last updated: 2024-12-31